SLDB Solid Corp: Bozor kapitallashuvining balans qiymatiga nisbati

Solid Bio (SLDB) kompaniyasining rasmiy ramzlari

Solid Biosciences Inc. (SLDB) Duchenne mushak distrofiyasida mushak funksiyalarini tiklash uchun inqilobiy usullarni yaratishga e'tibor qaratadi va uning ishlanmalari hozirda hal qiluvchi sinov bosqichlariga kirmoqda. Eksklyuziv patentlarga egalik qilish uzoq muddatli bozor ustunligini kafolatlaydi va joriy ko'rsatkich 1.62 ni tashkil etadi. Ushbu grafikdagi chiziqli narx harakati biznesga nisbatan bozor kutganlarini aks ettiradi. Xatarlar turli gen yetkazib berish tizimlari va erta bosqichdagi tadqiqotlarning keng portfelidan foydalanish orqali yumshatiladi.

Solid Corp (SLDB): Kapitallashuvning balans qiymatiga nisbati 04.07.2022dan 27.10.2026gacha

Solid Biosciences Inc (SLDB) moliyaviy va bozor koʻrsatkichlari kesimi

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya narxi Solid Biosciences Inc.|SLDB - Maqsadli narxlar grafigi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor kapitallashuvi Solid Bio|SLDB - Biznes qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya uchun sof aktivlar Solid Biosciences|SLDB - Buxgalteriya kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati solidbio.com|SLDB - Kompaniyaning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati Solid Biosciences Inc.|SLDB - Uzoq muddatli qarzdorlikning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Solid Bio|SLDB - Kompaniyaning umumiy yig'indi qarzi|Qarzning balans kapitallashuviga nisbati Solid Bio
Fundamental baholash:Solid Biosciences Inc.
Solid Bio tomonidan chiqariladigan mahsulotlar

Investorlar Solid Biosciences Inc. (SLDB) gen terapiyasining kengayish imkoniyatlarini narxning buxgalteriya qiymatiga nisbati orqali baholamoqdalar, bu ko'rsatkich joriy aktivlarga nisbatan kelajakdagi patentlar uchun bozor premiumini o'lchaydi. Kompaniyaning joriy bozor narxini uning buxgalteriya qiymatiga nisbatan tahlil qilish, tadqiqot va ishlanmalar (R&D) uchun naqd pullarning sarflanishi fonida adolatli baholash qidiruvini ochib beradi, bunda ko'paytiruvchining keskin pasayishi kapitalning qadrsizlanish xavfidan signal beradi.

Raqobatchilar tahlili

Tempus Labs (TEM) - Bozor kapitallashuvining balans qiymatiga nisbati|qiagen.com (QGEN) - Bozor qiymatining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati Ionis (IONS)|Kapitallashuvning balans qiymatiga nisbati RGEN|Bozor qiymatining balans qiymatiga nisbati Avidity RNA|Kapitallashuvning balans qiymatiga nisbati CRISPR (CRSP)|Bozor kapitallashuvining balans qiymatiga nisbati WGS (GeneDx Holdings Corp.)|ultragenyx.com - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati BEAM (Beam Therapeutics)|SRPT: Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati TWST|TXG (10x) - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor qiymatining balans qiymatiga nisbati Intellia Therapeutics|Bozor qiymatining balans qiymatiga nisbati stoketherapeutics.com|BLFS (BioLife Solutions) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi Wave Life Sciences Ltd (WVE)|MAZE - Bozor kapitallashuvining balans qiymatiga nisbati|SION - Kapitallashuvning balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Prime Medicine, Inc. (PRME)|TSHA - Balans qiymatiga nisbatan bozor qiymati|uniQure (QURE) - Bozor kapitallashuvining balans qiymatiga nisbati|MeiraGTx Holdings (MGTX) - Bozor qiymatining balans qiymatiga nisbati|RGNX: Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi OCGN|Pacific Biosciences - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti BNTC (benitec.com)|Bozor qiymatining balans qiymatiga nisbati DSGN|Balans qiymatiga nisbatan bozor kapitallashuvi Rocket Pharma RCKT|FDMT: Bozor kapitallashuvining balans qiymatiga nisbati|LXEO - Kapitallashuvning sof aktivlarga nisbati|korrobio.com - Bozor kapitallashuvining balans qiymatiga nisbati|editasmedicine.com (EDIT) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati SLN (Silence Therapeutics plc)|Bozor qiymatining balans qiymatiga koeffitsiyenti PRQR|Bozor qiymatining balans qiymatiga nisbati Codexis, Inc. CDXS|Kapitallashuvning balans qiymatiga nisbati Sangamo BioSciences (SGMO)|Nautilus Bio - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati metagenomi.co MGX|DTIL (Precision BioSciences) - Bozor kapitallashuvining balans qiymatiga nisbati|GBIO: Bozor qiymatining balans qiymatiga koeffitsiyenti|Boundless Bio, Inc - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi Exicure|IMNN - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati RXi Pharmaceuticals|MBIO (Mustang Bio, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi RNAZ (transcodetherapeutics.com)|BNGO - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati Applied DNA Corp APDN|BLUE: Bozor kapitallashuvining balans qiymatiga nisbati|ImmunoPrecise Antibodies (IPA) - Kapitallashuvning sof aktivlarga nisbati|Omega Therapeutics, Inc. - Kapitallashuvning sof aktivlarga nisbati|OMIC (Singular Genomics Systems, Inc.) - Balans qiymatiga nisbatan bozor kapitallashuvi|RGLS: Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi SYRS|Bozor qiymatining balans qiymatiga nisbati Telesis Bio, Inc. (TBIO)|Bozor qiymatining balans qiymatiga nisbati traconpharma.com (TCON)|UBX - Bozor kapitallashuvining balans qiymatiga nisbati